Summary
The depolarization-evoked release of γ-aminobutyric acid (GABA) and its possible modulation mediated by autoreceptors were studied in nerve endings isolated from rat spinal cord and prelabeled with the radioactive aminoacid. In the presence of the GABA uptake inhibitor SK&F 89976A [N-(4,4-diphenyl-3-butenyl)-nipecotic acid], used to minimize carrier-mediated homoexchange, exogenous GABA (1–10 µmol/l) decreased in a concentration-dependent way the release of3H-GABA evoked by 15 mmol/l KCl. The GABAA receptor agonist muscimol (10–100 µmol/l) did not affect the K+(15 mmol/l)-evoked3H-GABA release. Similarly ineffective was the GABAB receptor agonist (−)-baclofen (3–100 µmol/l). The effect of GABA was not counteracted by the GABAA receptor antagonists bicuculline,picrotoxinorSR95531 [2-(3′-carbethoxy-2′-propenyl)-3-amino-6-paramethoxy-phenyl-pyridazinium bromide]. In a set of experiments performed in parallel with spinal cord or cerebral cortex synaptosomes depolarized with 9 mmol/l KCI it was found that: (a) GABA (1–10 µmol/l) decreased in a concentration-dependent way the release of3H-GABA in both brain regions and its effects were practically doubled when compared with those in synaptosomes depolarized with 15 mmol/l KCI; - (b) muscimol (1–100 µmol/l) was ineffective both in spinal cord and in cerebral cortex; - (c) (−)-baclofen (1-100 µmol/l) concentration-dependently inhibited3H-GABA release in cerebral cortex synaptosomes but was almost inactive in the spinal cord; the (+)-enantiomer of baclofen (100 µmol/l) did not affect significantly the release of3H-GABA; - (d) the GABAB receptor antagonist phaclofen [3-amino-2-(4chlorophenyl)-propyl phosphonic acid] antagonized the effect of GABA in cerebral cortex but not in spinal cord synaptosomes. It is concluded that the release of GABA in rat spinal cord may be modulated by an autoreceptor which does not belong to the known GABA receptor subtypes.
Similar content being viewed by others
References
Anderson RA, Mitchell R (1985) Evidence for GABAB autoreceptors in median eminence. Eur J Pharmacol 18:355–358
Bonanno G, Raiteri M (1987) Coexistence of carriers for dopamine and GABA uptake on a same nerve terminal in the rat brain. Br J Pharmacol 91:237–243
Bonanno G, Cavazzani P, Andrioli GC, Asaro D, Pellegrini G, Raiteri M (1989a) The human cerebral cortex is endowed with release-regulating autoreceptors of the GABAB type. Br J Pharmacol 96:341–346
Bonanno G, Pellegrini G, Asaro D, Fontana G, Raiteri M (1989b) GABAB autoreceptors in rat cortex synaptosomes: response under different depolarizing and ionic conditions. Eur J Pharmacol 172:41–49
Bowery NG, Hill DR, Hudson AL, Doble A, Middlemiss DN, Shaw J, Turnbull M (1980) (−)-Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature (Lond) 283:92–94
Bowery NG (1983) Classification of GABA receptors. In: Enna SJ (ed) The GABA Receptors. Humana Press, Clifton, NJ, pp 177–213
DeFeudis FV (1983) γ-Aminobutyric acid and cardiovascular function. Experientia 39:845–849
Drukarch B, Schepens E, Schoffelmeer ANM, Stoof JC (1989) Stimulation of D-2 dopamine receptors decreases the evoked in vitro release of [3H]acetylcholine from rat neostriatum: role of K+ and Ca2+. J Neurochem 52:1680–1685
Dutar P, Nicoll RA (1988) A physiological role for GABAB receptors in the central nervous system. Nature (Lond) 332:156–158
Floran B, Silva I, Nava C, Aceves J (1988) Presynaptic modulation of the release of GABA by GABAA receptors in pars compacta and by GABAB receptors in pars reticulata of the rat substantia nigra. Eur J Pharmacol 150:277–286
Gray EG, Whittaker VP (1962) The isolation of nerve endings from brain: an electron microscopic study of cell fragments derived by homogenization and centrifugation. J Anat 96:79–87
Kerr DIB, Ong J, Prager RH, Gynther BD, Curtis DR (1987) Phaclofen: a peripheral and central baclofen antagonist. Brain Res 405:150–154
Larsson OM, Falch E, Krogsgaard-Larsen P, Schousboe A (1988) Kinetic characterization of inhibition of γ-aminobutyric acid uptake into cultured neurons and astrocytes by 4,4-diphenyl-3 butenyl derivatives of nipecotic acid and guvacine. J Neurochem 50:818–823
Levi G, Raiteri M (1974) Exchange of neurotransmitter amino acid at nerve endings can simulate high affinity uptake. Nature 250:735–737
Morselli PL, Lloyd KG (1983) Clinical pharmacology of GABA agonists. In: Enna SJ (ed) The GABA Receptors. Humana Press, Clifton, NJ, pp 305–336
Petersen GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346–356
Pittaluga A, Asaro D, Pellegrini G, Raiteri M (1987) Studies on3H-GABA and endogenous GABA release in rat cerebral cortex suggest the presence of autoreceptors of the GABAB type. Eur J Pharmacol 144:45–52
Raiteri M, Angelini F, Levi G (1974) A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol 25:411–414
Raiteri M, Bonanno G, Marchi M, Maura G (1984) Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? J Pharmacol Exp Ther 231:671–677
Waldmeier PC, Wicki P, Feldtrauer J-J, Baumann PA (1988) Potential involvement of a Baclofen-sensitive autoreceptor in the modulation of the release of endogenous GABA from rat brain slices in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 337: 289–295
Wermuth CG, Bizière K (1986) Pyridazinyl-GABA derivatives: a new class of synthetic GABAA antagonists. Trends Pharmacol Sci 7:421–424
Williams M (1983) Anxioselective anxiolytics. J Med Chem 26:619–628
Yunger LM, Fowler PJ, Zarevics P, Setler PE (1984) Novel inhibitors of γ-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice. J Pharmacol Exp Ther 228:109–115
Author information
Authors and Affiliations
Additional information
Send offprint requests to M. Raiteri at the above address
Rights and permissions
About this article
Cite this article
Raiteri, M., Pellegrini, G., Cantoni, C. et al. A novel type of GABA receptor in rat spinal cord?. Naunyn-Schmiedeberg's Arch. Pharmacol. 340, 666–670 (1989). https://doi.org/10.1007/BF00717742
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00717742